With MedMAP, Agion combines the expertise of the manufacturer’s development team with the expertise of the Agion team of materials scientists, microbiologists, and regulatory experts. Agion Technologies has claimed that MedMap moves products from concept to development, through regulatory approvals to commercialization.
Paul Ford, CEO, Agion, said: “Agion created MedMAP to deliver on a true partnership business model. Agion has a long history of partnering with manufacturers to develop, successfully file and gain global approvals for medical devices featuring our silver ion technology. Our expertise and knowledge can greatly accelerate the process for our partners.”
